Tag: AVEO,EGFR,EGFR TKI therapy,ESMO,HGF inhibitory antibody,In the News,NSCLC,Non-Small Cell Lung Cancer,TKI,Veristrat,gefitinib,oncology

Exploratory Analysis of Patients with NSCLC | Biodesix

VeriStrat “Poor” Patients Show Encouraging Overall Survival and Progression Free Survival Signal; Confirmatory Phase 2 Study Planned by Year-End

September 24, 2014